Sponsor study identifier
observational
70
1 country
4
Study Start
July 2, 2025
Actual (reported)Primary Completion
April 25, 2026
Actual (reported)Study Completion
April 25, 2026
Actual (reported)This exploratory clinical study, NEURO-CARD-2, will use simultaneous functional near-infrared spectroscopy (fNIRS) and electrocardiography (ECG) to investigate interhemispheric dysfunction in the dorsolateral prefrontal cortex (DLPFC) and its association with autonomic sympathetic activation in women with recurrent pregnancy loss (RPL) and comorbid anxiety. Using a standardized multisensory aversive emotional stimulation paradigm, the study will assess cortical and cardiac responses within a Brain-Heart-Emotion interaction framework. The objective will be to identify neurobiological signatures of emotion-autonomic dysregulation in this population and to inform the future development of precision-targeted interventions.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 25, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 22, 2025
Actual (reported)July 1, 2025
Actual (reported)July 2, 2025
Actual (reported)April 25, 2026
Actual (reported)April 25, 2026
Actual (reported)Group-dependent hemispheric asymmetry of DLPFC activation during aversive emotional stimulation (group × hemisphere interaction)
The primary endpoint will be the group-by-hemisphere interaction in task-evoked DLPFC HbO activation during aversive emotional stimulation, comparing women with recurrent pregnancy loss (RPL) with anxiety versus without anxiety. Hemisphere will be defined as right versus left DLPFC, measured within the same participant. The participant-level activation metric will be the DLPFC HbO response estimate (β) derived from the prespecified fNIRS analysis pipeline. The primary hypothesis will be tested using a linear mixed-effects model (LME) fitted by restricted maximum likelihood, with prespecified covariates including age, education, body mass index, miscarriage etiology category, and resting heart rate. The primary confirmatory test will evaluate whether the right-minus-left difference in DLPFC activation differs by group.
Single-session fNIRS-ECG protocol (Day 1)
Group difference in interhemispheric synchronization of DLPFC activity
Single-session fNIRS-ECG protocol (Day 1)
Group difference in mean heart-rate increase during aversive emotional stimulation
Single-session fNIRS-ECG protocol (Day 1)
Support vector machine discrimination of individual joint WTC-HR response profiles in recurrent pregnancy loss with versus without anxiety
Single-session fNIRS-ECG protocol (Day 1)
Comparison of adverse events (AEs) and serious adverse events (SAEs) between groups
Single-session fNIRS-ECG protocol (Day 1)
Interhemispheric DLPFC coordination as a mediator of the association between anxiety status and task-evoked heart-rate response in recurrent pregnancy loss
Single-session fNIRS-ECG protocol (Day 1)
Women with recurrent pregnancy loss who will meet DSM-5 criteria for a comorbid anxiety disorder. Participants in this cohort will undergo the same protocol-assigned multisensory aversive stimulation paradigm during simultaneous fNIRS and ECG recording. This cohort will be compared with women with recurrent pregnancy loss without comorbid anxiety to evaluate DLPFC activation, interhemispheric coherence, heart-rate responses, and brain-heart coupling features.
Women with recurrent pregnancy loss who will not meet DSM-5 criteria for a comorbid anxiety disorder. Participants in this cohort will undergo the same protocol-assigned multisensory aversive stimulation paradigm during simultaneous fNIRS and ECG recording. This cohort will serve as the comparison group for evaluating DLPFC activation, interhemispheric coherence, heart-rate responses, and brain-heart coupling features.
Participants will undergo a standardized multisensory aversive stimulation paradigm during simultaneous fNIRS and ECG recording. The protocol will use a block design with 12 stimulation blocks, each comprising a 20 s resting phase followed by a 30 s multisensory stimulation phase. During stimulation, participants will view six negative high-arousal images per block selected from the Geneva Affective Picture Database, while concurrently being exposed to time-locked band-limited white noise calibrated to approximately 90 dB(A) and placing both hands on a 0.5 liter bottle filled with ice water maintained at approximately 0 °C. The auditory stimulus will have spectral energy restricted to 2-6 kHz. This standardized multisensory protocol will be used to elicit negative affect and sympathetic arousal.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Recruitment is expected to occur through obstetrics and gynecology outpatient clinics, as well as community outreach via flyers and media campaigns.
The Second Affiliated Hospital of Shenyang Medical College
Shenyang, Liaoning, 110001, China
Central Hospital Affiliated to Shenyang Medical College
Shenyang, Liaoning, 110024, China
157 Hospital of Liaoning Health Industry Group
Shenyang, Liaoning, 110045, China
242 Hospital Affiliated to Shenyang Medical College
Shenyang, Liaoning, 110086, China
Yun-En Liu, MD
Shenyang Medical College
Lin Tao, MM
Shenyang Medical College
Fei Meng, MD
Central Hospital Affiliated to Shenyang Medical Collage
Xiu-Ling Zhang, MD
The Second Hospital of Shenyang Medical College
70 participants (actual enrollment reported by the registry).
First Submitted
June 22, 2025
First Posted
July 1, 2025
Study Start
July 2, 2025
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
April 25, 2026
Actual (reported)Study Completion
April 25, 2026
Actual (reported)Last Updated
August 18, 2026
Record last verified: 2025-09
De-dentified individual participant data, together with the full study protocol, MATLAB analysis scripts, and all supporting materials, will be released in full at the time of publication of the final manuscript. All materials will be deposited on one internationally recognized open science repository selected by the research team, such as Open Science Framework (https://osf.io), Zenodo (https://zenodo.org), or GitHub (https://github.com). Access will be granted for non-commercial research purposes. Requests for additional information may be directed to the corresponding author.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: